$0.00040
0.000.00%
At close: -
Comments
Loading...
Ethema Health Analyst Ratings and Price Targets | OTC:GRST | Benzinga
Ethema Health Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Ethema Health Corp from these most-recent analyst ratings.
Analyst Ratings for Ethema Health
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Ethema Health (GRST) stock?
There is no price target for Ethema Health
What is the most recent analyst rating for Ethema Health (GRST)?
There is no analyst for Ethema Health
When was the last upgrade for Ethema Health (GRST)?
There is no last upgrade for Ethema Health
When was the last downgrade for Ethema Health (GRST)?
There is no last downgrade for Ethema Health.
When is the next analyst rating going to be posted or updated for Ethema Health (GRST)?
There is no next analyst rating for Ethema Health.
Is the Analyst Rating Ethema Health (GRST) correct?
There is no next analyst rating for Ethema Health.
Browse analyst ratings and price targets on all stocks.
